InsiderTrades.com logo
Election warning coming true…
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - watch it before it's too late.
Click here to watch it now.
Eric J. Loumeau net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Eric Loumeau Biography and Net Worth

COO of AnaptysBio
Eric Loumeau joined AnaptysBio in August 2018 with more than twenty years of experience in biotech. Mr. Loumeau’s expertise includes corporate finance, raising over $5 billion in over 75 public and private securities offerings, and mergers and acquisitions. Mr. Loumeau previously served as General Counsel and Chief Compliance Officer of Otonomy, Inc. Before joining Otonomy, Mr. Loumeau served as Chief Financial Officer of Rempex Pharmaceuticals, Inc., and continued as Vice President of Legal Affairs following Rempex’s acquisition by The Medicines Company. He also previously functioned as General Counsel at Hollis-Eden Pharmaceuticals, Inc. Mr. Loumeau’s experience as outside corporate counsel at national law firms includes tenures at Skadden, Arps, Slate, Meagher & Flom LLP, Cooley LLP, Mintz Levin Cohn Ferris Glovsky and Popeo PC, and Bass, Berry & Sims PLC. Mr. Loumeau received his J.D. from Boalt Hall School of Law at the University of California, Berkeley, and his B.S. in Finance from Brigham Young University.

What is Eric J. Loumeau's net worth?

The estimated net worth of Eric J. Loumeau is at least $142,576.20 as of September 16th, 2024. Mr. Loumeau owns 7,020 shares of AnaptysBio stock worth more than $142,576 as of November 21st. This net worth evaluation does not reflect any other assets that Mr. Loumeau may own. Additionally, Mr. Loumeau receives a salary of $685,590.00 as COO at AnaptysBio. Learn More about Eric J. Loumeau's net worth.

How old is Eric J. Loumeau?

Mr. Loumeau is currently 61 years old. There are 5 older executives and no younger executives at AnaptysBio. The oldest executive at AnaptysBio is Mr. Dennis M. Mulroy, Chief Financial Officer, who is 69 years old. Learn More on Eric J. Loumeau's age.

What is Eric J. Loumeau's salary?

As the COO of AnaptysBio, Inc., Mr. Loumeau earns $685,590.00 per year. The highest earning executive at AnaptysBio is Mr. Daniel R. Faga, President, CEO & Director, who commands a salary of $867,120.00 per year. Learn More on Eric J. Loumeau's salary.

How do I contact Eric J. Loumeau?

The corporate mailing address for Mr. Loumeau and other AnaptysBio executives is 10421 PACIFIC CENTER COURT SUITE 200, SAN DIEGO CA, 92121. AnaptysBio can also be reached via phone at (858) 362-6295 and via email at [email protected]. Learn More on Eric J. Loumeau's contact information.

Has Eric J. Loumeau been buying or selling shares of AnaptysBio?

Eric J. Loumeau has not been actively trading shares of AnaptysBio over the course of the past ninety days. Most recently, Eric J. Loumeau sold 8,720 shares of the business's stock in a transaction on Monday, September 16th. The shares were sold at an average price of $39.82, for a transaction totalling $347,230.40. Following the completion of the sale, the insider now directly owns 7,020 shares of the company's stock, valued at $279,536.40. Learn More on Eric J. Loumeau's trading history.

Who are AnaptysBio's active insiders?

AnaptysBio's insider roster includes Eric Loumeau (COO), and Hamza Suria (CEO). Learn More on AnaptysBio's active insiders.

Are insiders buying or selling shares of AnaptysBio?

In the last twelve months, AnaptysBio insiders bought shares 1 times. They purchased a total of 273,972 shares worth more than $9,999,978.00. In the last twelve months, insiders at the biotechnology company sold shares 16 times. They sold a total of 208,827 shares worth more than $5,229,469.83. The most recent insider tranaction occured on September, 23rd when insider Paul F Lizzul sold 1,500 shares worth more than $58,005.00. Insiders at AnaptysBio own 33.7% of the company. Learn More about insider trades at AnaptysBio.

Information on this page was last updated on 9/23/2024.

Eric J. Loumeau Insider Trading History at AnaptysBio

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/16/2024Sell8,720$39.82$347,230.407,020View SEC Filing Icon  
2/16/2024Sell5,000$25.00$125,000.003,240View SEC Filing Icon  
11/22/2023Sell882$14.19$12,515.58View SEC Filing Icon  
9/18/2023Sell3,895$19.32$75,251.40882View SEC Filing Icon  
6/8/2022Sell2,500$24.00$60,000.00523View SEC Filing Icon  
5/18/2022Sell1,146$20.50$23,493.00523View SEC Filing Icon  
11/4/2021Sell5,000$35.00$175,000.00View SEC Filing Icon  
2/12/2021Sell10,000$35.00$350,000.0010,000View SEC Filing Icon  
See Full Table

Eric J. Loumeau Buying and Selling Activity at AnaptysBio

This chart shows Eric J Loumeau's buying and selling at AnaptysBio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

AnaptysBio Company Overview

AnaptysBio logo
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics. Its products include Rosnilimab, an IgG1 antibody that targets PD-1+ T cells, resulting in their agonism or depletion, broadly impacting pathogenic drivers of autoimmune and inflammatory diseases; and ANB032, a non-depleting antibody that binds to the BTLA checkpoint receptor and inhibits activated T cell proliferation; ANB033, a novel anti-CD122 antagonist antibody that targets the shared common beta subunit of the receptors for IL-15 and IL-2; ANB101, a BDCA2 modulator antibody that specifically targets plasmacytoid dendritic cells (pDCs); and Imsidolimab, an antibody that inhibits the interleukin-36 receptor, which is in the Phase 3 development for the treatment of generalized pustular psoriasis. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Read More

Today's Range

Now: $20.31
Low: $19.58
High: $20.58

50 Day Range

MA: $30.42
Low: $18.88
High: $40.33

2 Week Range

Now: $20.31
Low: $13.36
High: $41.31

Volume

345,686 shs

Average Volume

352,044 shs

Market Capitalization

$618.03 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Election warning coming true…
From Porter & Company   |   Ad
If you missed it, my emergency election broadcast is now available - watch it before it's too late.
Click here to watch it now.